Pharmala Biotech HoldingsMDMA 
$0.060.00%24h
0.00%24h
Global rank34389
Market cap$5.28M
Change 7d-5.56%
YTD Performance-41.38%
SP500 benchmarkUnderperform
P/E-6.24
P/S13.51
Revenue$390.76K
Earnings-$572.78K
Dividend yield-
Main Sector
Healthcare
Category
EPS for Pharmala Biotech Holdings (MDMA)
Pharmala Biotech Holdings has an EPS of $-0.01. In 2022, the company made an earnings per share (EPS) of $-0.01. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for MDMA
-
Value:-
EPS history for Pharmala Biotech Holdings from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.01 | 0.00% |
| 2022 | -$0.01 | -66.92% |
| 2021 | -$0.03023 | - |
View the highest EPS stocks
